Sign up for our complimentary
weekly e-journal

Main Newsletter
Mastery Series
Therapy Series
 
Bookmark and Share | Print Article | Test Your Knowledge Answers Previous | All Articles This Week | Next
This article originally posted 24 March, 2012 and appeared in  Issue 436

Test Your Knowledge Answer #436

Advertisement

Answer and Critique (Correct Answer = D. Decrease the insulin glargine dosage by 20% and withhold insulin lispro in the morning)

Key Points:

  • Insulin should not be withheld in surgical patients with probable insulin deficiency.
  • In addition to patients who have type 1 diabetes, other patients may also have insulin deficiency.
  • The insulin glargine dosage should be unchanged or decreased by approximately 20% if a patient must fast; the adjustment depends on prior dietary, insulin use, and blood glucose history.
In addition to patients who have type 1 diabetes, patients with other types of diabetes may also have insulin deficiency. Characteristics of patients with potentially severe insulin deficiency include a prior history of diabetic ketoacidosis, prior pancreatic surgery, severe pancreatic dysfunction, a history of an extended duration of diabetes and insulin use, or a history of metabolic instability. These patients are at very high risk for ketoacidosis, so insulin should not be withheld in these patients.Although insulin infusion is the preferred method of glycemic control during surgery because it offers the most flexibility, this option is not always available. Instead, patients are frequently asked to adjust their outpatient regimens in preparation for surgery. Insulin glargine is a basal insulin; therefore, the dosage is typically unchanged or reduced by 20% if a patient will not eat for the day. Patients who have fasting blood glucose below 80 mg/dL (4.44 mmol/L) or who snack frequently during the day typically need a small reduction in dosage when fasting. They frequently do not have the typical insulin use of 50% basal/50% bolus; instead, a larger percentage of their insulin is basal insulin. Patients who do not snack and do not take additional insulin typically do not require such a dosage reduction. Rapid-acting insulin analogues may be used to treat acute hyperglycemia but at a reduced dosage because the prandial component is not required while the patient is not eating. Patients taking neutral protamine Hagedorn (NPH) insulin typically halve their morning dosage because NPH insulin has both basal and prandial components. These adjustments are only general suggestions—changes must be individualized for each patient.
 
Bibliography
  1. American Diabetes Association Diabetes in Hospitals Writing Committee. Management of diabetes and hyperglycemia in hospitals. Diabetes Care. 2004;27:553-91. [PMID: 14747243] [PubMed]
  2. American College of Endocrinology Task Force on Inpatient Diabetes Metabolic Control. American College of Endocrinology position statement on inpatient diabetes and metabolic control. Endocr Pract. 2004;10:77-82. [PMID: 15251626] [PubMed]
  3. Marks JB. Perioperative management of diabetes. Am Fam Physician. 2003;67:93-100. [PMID: 12537172] [PubMed]
Copyright © 2008 Diabetes In Control, Inc.  

Need a review of your diabetes knowledge? Check out all of our questions on our Test Your Knowledge pages.

 

Advertisement


 

Bookmark and Share | Print | Category | Home

This article originally posted 24 March, 2012 and appeared in  Issue 436

Past five issues: Diabetes Clinical Mastery Series Issue 141 | Issue 681 | Diabetes Clinical Mastery Series Issue 140 | Issue 680 | Diabetes Clinical Mastery Series Issue 139 |

 
Diabetes In Control Advertisers
 
Cast Your Vote
If the FDA relaxes prescribing restrictions on Avandia, will you recommend it?

Navigate Diabetes In Control
Search Articles On Diabetes In Control